GGrantIndex
← Leaderboards

Jin Ye

Ut Southwestern Medical Center

$5,774,990
Attributed
$5,774,990
Total exposure
3
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $571.5K · FY201025
$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$5,774,990 · 3

By mechanism

R01$3,563,940 · 2
R35$2,211,050 · 1

Top collaborators

No co-investigators on record.

Most similar at Ut Southwestern Medical Center

Same institution · by research overlap

Others in their field

Top investigators on “Proteins

Research focus

ProteinsMembraneRegulationMediatingIntegral Membrane ProteinPhysiologicalAdoptedCeramidesFamilyProteolysisMembrane ProteinsPharmaceutical PreparationsN-TerminalTranscription FactorCell NucleusUnited StatesBaseCcr5 GeneProtein TranslocationProteomeBasic ScienceMammalian CellHuman DiseaseCombat

Grant awards (15)

Topological regulation of transmembrane proteins through Regulated Alternative Translocation$410,000
R35 · FY2025 · GM · contact PI
Topological regulation of transmembrane proteins through Regulated Alternative Translocation$410,000
R35 · FY2024 · GM · contact PI
Topological regulation of transmembrane proteins through Regulated Alternative Translocation$410,000
R35 · FY2023 · GM · contact PI
Topological regulation of transmembrane proteins through Regulated Alternative Translocation$161,467
R35 · FY2023 · GM · contact PI
Topological regulation of transmembrane proteins through Regulated Alternative Translocation$410,000
R35 · FY2022 · GM · contact PI
Topological regulation of transmembrane proteins through Regulated Alternative Translocation$409,583
R35 · FY2021 · GM · contact PI
Proteolytic activation of CREB3L1 in treating cancers and tissue fibrosis$405,000
R01 · FY2018 · GM · contact PI
Proteolytic activation of CREB3L1 in treating cancers and tissue fibrosis$405,000
R01 · FY2017 · GM · contact PI
Proteolytic activation of CREB3L1 in treating cancers and tissue fibrosis$404,791
R01 · FY2016 · GM · contact PI
Proteolytic activation of CREB3L1 in treating cancers and tissue fibrosis$403,750
R01 · FY2015 · GM · contact PI
Regulated Intramembrane Proteolysis of CREB3L1 in Innate Antiviral Response$393,525
R01 · FY2014 · AI · contact PI
Regulated Intramembrane Proteolysis of CREB3L1 in Innate Antiviral Response$369,914
R01 · FY2013 · AI · contact PI
Regulated Intramembrane Proteolysis of CREB3L1 in Innate Antiviral Response$393,422
R01 · FY2012 · AI · contact PI
Regulated Intramembrane Proteolysis of CREB3L1 in Innate Antiviral Response$392,288
R01 · FY2011 · AI · contact PI
Regulated Intramembrane Proteolysis of CREB3L1 in Innate Antiviral Response$396,250
R01 · FY2010 · AI · contact PI